Two small-cap biotech stocks -- OncoGenex Pharmaceuticals(OGXI Quote) and Oxigene(OXGN Quote) -- are generating buzz and a lot of investor interest with the start of a major cancer research conference just a few days away.
The American Society of Clinical Oncology (ASCO) annual meeting kicks off Friday and runs through Tuesday in Orlando. Wall Street typically regards the ASCO meeting as the Super Bowl of cancer drug research. This year, however, the event more resembles a large county fair due to the paucity of groundbreaking clinical data expected to emerge from five days of presentations.
That doesn't mean investors aren't paying attention, and this year's focus leading up the meeting has definitely been on small-cap cancer drug stocks. ...
Recent Comments
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note | |
|---|---|---|---|---|
| 10,310.98 | 1,099.38 | 2,201.34 | 35.39 |
Oil *
73.94
|
|
UP
2.72
|
UP
3.31
|
UP
21.29
|
UP
0.52
|
10 Yr
3.54%
SPDR Gold
109.23
|
|
+0.03%
|
+0.30%
|
+0.98%
|
+1.49%
|
Data delayed 20 minutes |
Connect with TheStreet